Oxford BioDynamics Plc (LON:OBD – Get Free Report) fell 5.3% during trading on Thursday . The company traded as low as GBX 0.45 ($0.01) and last traded at GBX 0.48 ($0.01). 61,511,520 shares traded hands during trading, an increase of 91% from the average session volume of 32,278,898 shares. The stock had previously closed at GBX 0.51 ($0.01).
Oxford BioDynamics Stock Performance
The firm has a market cap of £8.92 million, a P/E ratio of -0.08 and a beta of 0.42. The firm’s fifty day moving average price is GBX 0.91 and its 200 day moving average price is GBX 2.73. The company has a debt-to-equity ratio of 370.22, a quick ratio of 2.80 and a current ratio of 0.68.
About Oxford BioDynamics
Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.
In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.
Featured Stories
- Five stocks we like better than Oxford BioDynamics
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Insider Trading – What You Need to Know
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.
